These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 25128454)

  • 1. Standard cardiovascular disease risk algorithms underestimate the risk of cardiovascular disease in schizophrenia: evidence from a national primary care database.
    McLean G; Martin JL; Martin DJ; Guthrie B; Mercer SW; Smith DJ
    Schizophr Res; 2014 Oct; 159(1):176-81. PubMed ID: 25128454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular risk prediction in a population with the metabolic syndrome: Framingham vs. UKPDS algorithms.
    Zomer E; Liew D; Owen A; Magliano DJ; Ademi Z; Reid CM
    Eur J Prev Cardiol; 2014 Mar; 21(3):384-90. PubMed ID: 22588087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Established cardiovascular disease and CVD risk factors in a primary care population of middle-aged Irish men and women.
    Creagh D; Neilson S; Collins A; Colwell N; Hinchion R; Drew C; O'Halloran D; Perry IJ
    Ir Med J; 2002; 95(10):298-301. PubMed ID: 12542011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of short and lifetime risks for cardiovascular disease in Italians.
    Di Castelnuovo A; Costanzo S; Persichillo M; Olivieri M; de Curtis A; Zito F; Donati MB; de Gaetano G; Iacoviello L;
    Eur J Prev Cardiol; 2012 Aug; 19(4):723-30. PubMed ID: 21571772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Web-based assessment of cardiovascular disease risk in routine primary care practice in New Zealand: the first 18,000 patients (PREDICT CVD-1).
    Bannink L; Wells S; Broad J; Riddell T; Jackson R
    N Z Med J; 2006 Nov; 119(1245):U2313. PubMed ID: 17146488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of cardiovascular disease risk amongst the population eligible for the NHS Health Check Programme.
    Dalton AR; Soljak M; Samarasundera E; Millett C; Majeed A
    Eur J Prev Cardiol; 2013 Feb; 20(1):142-50. PubMed ID: 22058079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive accuracy of the 'Framingham's general CVD algorithm' in a Middle Eastern population: Tehran Lipid and Glucose Study.
    Bozorgmanesh M; Hadaegh F; Azizi F
    Int J Clin Pract; 2011 Mar; 65(3):264-73. PubMed ID: 21314863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global cardiovascular risk associated with hypertension and extent of treatment and control according to risk group.
    Wong ND; Dede J; Chow VH; Wong KS; Franklin SS
    Am J Hypertens; 2012 May; 25(5):561-7. PubMed ID: 22318511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schizophrenia and the risk of cardiovascular diseases: a meta-analysis of thirteen cohort studies.
    Fan Z; Wu Y; Shen J; Ji T; Zhan R
    J Psychiatr Res; 2013 Nov; 47(11):1549-56. PubMed ID: 23953755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of Framingham cardiovascular risk scores by ethnic groups in New Zealand: PREDICT CVD-10.
    Riddell T; Wells S; Jackson R; Lee AW; Crengle S; Bramley D; Ameratunga S; Pylypchuk R; Broad J; Marshall R; Kerr A
    N Z Med J; 2010 Feb; 123(1309):50-61. PubMed ID: 20186242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initiation and maintenance of cardiovascular medications following cardiovascular risk assessment in a large primary care cohort: PREDICT CVD-16.
    Mehta S; Wells S; Grey C; Riddell T; Kerr A; Marshall R; Ameratunga S; Harrison J; Kenealy T; Bramley D; Chan WC; Thornley S; Sundborn G; Jackson R
    Eur J Prev Cardiol; 2014 Feb; 21(2):192-202. PubMed ID: 23033546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular diseases among patients with schizophrenia.
    Azad MC; Shoesmith WD; Al Mamun M; Abdullah AF; Naing DK; Phanindranath M; Turin TC
    Asian J Psychiatr; 2016 Feb; 19():28-36. PubMed ID: 26957335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of cardiovascular risk factors and disease in people with schizophrenia: a population-based study.
    Bresee LC; Majumdar SR; Patten SB; Johnson JA
    Schizophr Res; 2010 Mar; 117(1):75-82. PubMed ID: 20080392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular disease knowledge and risk perception among underserved individuals at increased risk of cardiovascular disease.
    Homko CJ; Santamore WP; Zamora L; Shirk G; Gaughan J; Cross R; Kashem A; Petersen S; Bove AA
    J Cardiovasc Nurs; 2008; 23(4):332-7. PubMed ID: 18596496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of different point-of-care testing lipid analysers on cardiovascular disease risk assessment.
    Whitehead SJ; Ford C; Gama R
    J Clin Pathol; 2014 Jun; 67(6):535-9. PubMed ID: 24711512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does diagnosis of the metabolic syndrome detect further men at high risk of cardiovascular death beyond those identified by a conventional cardiovascular risk score? The DECODE Study.
    DECODE Study Group
    Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):192-9. PubMed ID: 17446796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of a national cardiovascular disease risk assessment program (NHS Health Check): results after one year.
    Artac M; Dalton AR; Majeed A; Car J; Millett C
    Prev Med; 2013 Aug; 57(2):129-34. PubMed ID: 23701848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recalibration and validation of the SCORE risk chart in the Australian population: the AusSCORE chart.
    Chen L; Tonkin AM; Moon L; Mitchell P; Dobson A; Giles G; Hobbs M; Phillips PJ; Shaw JE; Simmons D; Simons LA; Fitzgerald AP; De Backer G; De Bacquer D
    Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):562-70. PubMed ID: 19741542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender differences in the prevalence, causes and treatment of high cardiovascular risk: findings from the FINRISK Survey.
    Lehto HR; Lehto S; Havulinna AS; Jousilahti P; Salomaa V
    Eur J Prev Cardiol; 2012 Oct; 19(5):1153-60. PubMed ID: 21890534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Under-utilisation of preventive medication in patients with cardiovascular disease is greatest in younger age groups (PREDICT-CVD 15).
    Mehta S; Wells S; Riddell T; Kerr A; Pylypchuk R; Marshall R; Ameratunga S; Chan WC; Thornley S; Crengle S; Harrison J; Drury P; Elley CR; Bell F; Jackson R
    J Prim Health Care; 2011 Jun; 3(2):93-101. PubMed ID: 21625656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.